复发性宫颈癌中潜在的免疫治疗靶点
本研究对28例盆腔廓清术标本采用多重免疫荧光面板检测CD8、CD68、FoxP3、PD1和PD-L1,比较肿瘤内与瘤周间质的免疫细胞分布。结果显示细胞毒性T细胞、巨噬细胞和调节性T细胞在瘤周间质密度更高,瘤内巨噬细胞与调节性T细胞存在相关性。作者认为瘤内T细胞密度较低提示T细胞排斥或破坏,巨噬细胞可能参与免疫抑制微环境,未来联合治疗方向包括改变T细胞运输和靶向肿瘤相关巨噬细胞。
要点
- 瘤周间质中CD8+、CD68+、FoxP3+细胞密度均高于瘤内。
- 瘤内CD8+和CD68+中位密度均高于FoxP3+,但巨噬细胞与调节性T细胞存在相关性。
- 作者提出未来联合治疗可改变T细胞运输并靶向肿瘤相关巨噬细胞。
核心结论
- 瘤内细胞毒性T细胞密度低于瘤周间质,提示T细胞在瘤内被排斥或破坏。
- 瘤内巨噬细胞密度高于调节性T细胞,提示巨噬细胞可能参与免疫抑制微环境。
- 未来联合治疗方向包括改变T细胞运输和靶向肿瘤相关巨噬细胞(TAMs)以增强瘤内活化T细胞密度。
研究设计与样本
- 对复发性宫颈癌的盆腔廓清术存档标本(N=28)进行多重免疫荧光检测,抗体包括CD8、CD68、FoxP3、PD1和PD-L1。
- 临床数据从电子病历中提取。
主要发现
- 瘤周间质密度高于瘤内:CD8+密度497.7 vs 83.5(p<0.0001),CD68+密度345.0 vs 196.7(p=0.04),FoxP3+密度214.5 vs 35.6(p<0.0001)。
- 瘤周组织抗原经验T细胞(PD1+)中位归一化荧光强度高于肿瘤组织:0.05 vs 0.0085(p<0.001)。
- 瘤内CD8+中位密度83.5 vs FoxP3+ 35.6(p<0.05),瘤内CD68+中位密度196.7 vs FoxP3+ 35.6(p<0.05)。
- 瘤内巨噬细胞与调节性T细胞存在相关性:r=0.58,p=0.001。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Our objective was to characterize the intra and peritumoral immune profile in recurrent cervical cancers to identify rational immunotherapy targets. METHODS: Archival pelvic exenteration specimens were examined using a validated multiplex immuno-fluorescent panel of antibodies against cluster of differentiation 8 (CD8), cluster of differentiation 68 (CD68), forkhead box P3 (FoxP3), programmed cell death protein 1 (PD1), and programmed death-ligand 1 (PD-L1, N=28). Clinical data were abstracted from the electronic medical record. RESULTS: Cytotoxic T cells, macrophages, and regulatory T cells were found in higher densities in peritumoral stroma (CD8+ density 497.7 vs 83.5, p<0.0001, CD68+ density 345.0 vs 196.7, p=0.04, FoxP3+ density 214.5 vs 35.6, p<0.0001). Antigen experienced T cells (PD1+) were higher in peritumoral compared to tumor tissue (median normalized fluorescence intensity 0.05 vs 0.0085, p<0.001). Although there was a higher median density of intratumoral cytotoxic T cells and macrophages compared to regulatory T cells (median density CD8+ 83.5 vs 35.6, p<0.05, median density 196.7 vs 35.6, p<0.05), the presence of macrophages correlated with the presence of regulatory T cells in tumors (r=0.58, p=0.001). CONCLUSIONS: While cytotoxic T cells are present in tumor tissue to varying degrees, their density is lower than in peritumoral stroma, suggesting intratumoral exclusion or destruction of T cells. Higher densities of intratumoral macrophages compared to regulatory T cells suggest macrophages may be important contributors to the immunosuppressive tumor environment. Future directions for combination therapy include altering T cell trafficking and targeting tumor associated macrophages (TAMs) to enhance intratumoral activated T cell density and effect a more robust immune response.
引用
- Ring KL, Yemelyanova AV, Soliman PT, et al. Potential immunotherapy targets in recurrent cervical cancer. Gynecol Oncol. 2017. PMID: 28233576. doi:10.1016/j.ygyno.2017.02.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。